These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 15194494)

  • 1. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.
    Ittner LM; Luessi F; Koller D; Born W; Fischer JA; Muff R
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1203-9. PubMed ID: 15194494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1.
    Ittner LM; Koller D; Muff R; Fischer JA; Born W
    Biochemistry; 2005 Apr; 44(15):5749-54. PubMed ID: 15823033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
    Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
    Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical role for the short intracellular C terminus in receptor activity-modifying protein function.
    Udawela M; Christopoulos G; Morfis M; Christopoulos A; Ye S; Tilakaratne N; Sexton PM
    Mol Pharmacol; 2006 Nov; 70(5):1750-60. PubMed ID: 16912219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
    Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
    J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
    Naot D; Cornish J
    Bone; 2008 Nov; 43(5):813-8. PubMed ID: 18687416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP).
    Born W; Muff R; Fischer JA
    Microsc Res Tech; 2002 Apr; 57(1):14-22. PubMed ID: 11921352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three receptor-activity-modifying proteins define calcitonin gene-related peptide or adrenomedullin selectivity of the mouse calcitonin-like receptor in COS-7 cells.
    Husmann K; Born W; Fischer JA; Muff R
    Biochem Pharmacol; 2003 Dec; 66(11):2107-15. PubMed ID: 14609735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation.
    Granholm S; Lundberg P; Lerner UH
    J Cell Biochem; 2008 Jun; 104(3):920-33. PubMed ID: 18384073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution.
    Lennerz JK; Rühle V; Ceppa EP; Neuhuber WL; Bunnett NW; Grady EF; Messlinger K
    J Comp Neurol; 2008 Mar; 507(3):1277-99. PubMed ID: 18186028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors.
    Udawela M; Christopoulos G; Tilakaratne N; Christopoulos A; Albiston A; Sexton PM
    Mol Pharmacol; 2006 Jun; 69(6):1984-9. PubMed ID: 16531504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand binding and activation of the CGRP receptor.
    Conner AC; Simms J; Barwell J; Wheatley M; Poyner DR
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):729-32. PubMed ID: 17635135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refolding and characterization of a soluble ectodomain complex of the calcitonin gene-related peptide receptor.
    Koth CM; Abdul-Manan N; Lepre CA; Connolly PJ; Yoo S; Mohanty AK; Lippke JA; Zwahlen J; Coll JT; Doran JD; Garcia-Guzman M; Moore JM
    Biochemistry; 2010 Mar; 49(9):1862-72. PubMed ID: 20099900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function analysis of RAMP1 by alanine mutagenesis.
    Simms J; Hay DL; Bailey RJ; Konycheva G; Bailey G; Wheatley M; Poyner DR
    Biochemistry; 2009 Jan; 48(1):198-205. PubMed ID: 19072332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.
    Zumpe ET; Tilakaratne N; Fraser NJ; Christopoulos G; Foord SM; Sexton PM
    Biochem Biophys Res Commun; 2000 Jan; 267(1):368-72. PubMed ID: 10623626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms.
    Nikitenko LL; Blucher N; Fox SB; Bicknell R; Smith DM; Rees MC
    J Cell Sci; 2006 Mar; 119(Pt 5):910-22. PubMed ID: 16495482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiated response to adrenomedullin in myocardia and aortas in spontaneously hypertensive rat.
    Pan ChS; Jiang W; Wu ShY; Zhao J; Pang YZ; Tang ChS; Qi YF
    Basic Res Cardiol; 2006 May; 101(3):193-203. PubMed ID: 16450076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor.
    Salvatore CA; Mallee JJ; Bell IM; Zartman CB; Williams TM; Koblan KS; Kane SA
    Biochemistry; 2006 Feb; 45(6):1881-7. PubMed ID: 16460034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.
    McLatchie LM; Fraser NJ; Main MJ; Wise A; Brown J; Thompson N; Solari R; Lee MG; Foord SM
    Nature; 1998 May; 393(6683):333-9. PubMed ID: 9620797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.